Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
CC transcript
|
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/17/2021 |
8-K
| Quarterly results |
| 02/13/2018 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Agreement and Plan of Merger, by and among Charles River Laboratories International, Inc., Forest Acquisition Corporation, ACP Mountain Holdings, Inc. and, solely in its capacity as the Stockholders’ Representative, Avista Capital Partners IV GP, LP",
"Commitment Letter, between Charles River Laboratories International, Inc. and JPMorgan Chase Bank, N.A",
"Support Agreement, by and among Charles River Laboratories International, Inc., Avista Capital Holdings, L.P., Avista Capital Partners IV, L.P., Avista Capital Partners IV (Offshore), L.P. and ACP Mountain Co-Invest LLC and the other parties thereto",
"CHARLES RIVER LABORATORIES TO ACQUIRE MPI RESEARCH – Enhances Charles River’ s Position as a Leading Global Early-Stage CRO – – Transaction Expected to be Accretive to Non-GAAP EPS by Approximately $0.25 in 2018 and Approximately $0.60 in 2019 –" |
|
| 01/08/2016 |
8-K
| Acquisition/merger/asset purchase announced |
|
|